BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30119965)

  • 1. Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: A review.
    Power LC; O'Grady GL; Hornung TS; Jefferies C; Gusso S; Hofman PL
    Neuromuscul Disord; 2018 Sep; 28(9):717-730. PubMed ID: 30119965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Cardiac Magnetic Resonance Imaging in Boys With Duchenne Muscular Dystrophy Without Cardiac Disease.
    Power LC; Gusso S; Hornung TS; Jefferies C; Derraik JGB; Hofman PL; O'Grady GL
    Pediatr Neurol; 2021 Apr; 117():35-43. PubMed ID: 33662889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Cardiac Imaging Approaches in Duchenne Muscular Dystrophy.
    Poonja S; Power A; Mah JK; Fine NM; Greenway SC
    J Clin Neuromuscul Dis; 2018 Dec; 20(2):85-93. PubMed ID: 30439754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy.
    Lee S; Lee M; Hor KN
    Pediatr Pulmonol; 2021 Apr; 56(4):766-781. PubMed ID: 33651923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oedema-fibrosis in Duchenne Muscular Dystrophy: Role of cardiovascular magnetic resonance imaging.
    Mavrogeni S; Papavasiliou A; Giannakopoulou K; Markousis-Mavrogenis G; Pons MR; Karanasios E; Nikas I; Papadopoulos G; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
    Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy.
    Hor KN; Mah ML; Johnston P; Cripe TP; Cripe LH
    Neuromuscul Disord; 2018 Sep; 28(9):711-716. PubMed ID: 30064893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.
    Hammers DW; Sleeper MM; Forbes SC; Shima A; Walter GA; Sweeney HL
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27506543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac MRI biomarkers for Duchenne muscular dystrophy.
    Magrath P; Maforo N; Renella P; Nelson SF; Halnon N; Ennis DB
    Biomark Med; 2018 Nov; 12(11):1271-1289. PubMed ID: 30499689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A current approach to heart failure in Duchenne muscular dystrophy.
    D'Amario D; Amodeo A; Adorisio R; Tiziano FD; Leone AM; Perri G; Bruno P; Massetti M; Ferlini A; Pane M; Niccoli G; Porto I; D'Angelo GA; Borovac JA; Mercuri E; Crea F
    Heart; 2017 Nov; 103(22):1770-1779. PubMed ID: 28668906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
    Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.
    Fayssoil A; Abasse S; Silverston K
    J Neuromuscul Dis; 2017; 4(1):17-23. PubMed ID: 28269790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When Ejection Fraction Is Not Enough: The Search for Early Signs of Cardiomyopathy in Duchenne Muscular Dystrophy.
    Renella P; Lai WW
    Circ Cardiovasc Imaging; 2020 Nov; 13(11):e012003. PubMed ID: 33190535
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches in the therapy of cardiomyopathy in muscular dystrophy.
    McNally EM
    Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Marker of Myocardial Deformation in Children with Duchenne Muscular Dystrophy Assessed Using Echocardiographic Myocardial Strain Analysis.
    Jo WH; Eun LY; Jung JW; Choi JY; Gang SW
    Yonsei Med J; 2016 Jul; 57(4):900-4. PubMed ID: 27189283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duchenne Muscular Dystrophy: the Heart of the Matter.
    Shih JA; Folch A; Wong BL
    Curr Heart Fail Rep; 2020 Jun; 17(3):57-66. PubMed ID: 32270339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed left ventricular contractile reserve diagnosed by dobutamine stress echocardiography in a patient with Duchenne muscular dystrophy.
    Wong BL; Mukkada VA; Markham LW; Cripe LH
    J Child Neurol; 2005 Mar; 20(3):246-8. PubMed ID: 15832620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
    Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
    BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.